Champions Oncology
CSBR
9 hedge funds and large institutions have $18.7M invested in Champions Oncology in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
2% more capital invested
Capital invested by funds: $18.3M → $18.7M (+$370K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less funds holding
Funds holding: 12 → 9 (-3)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$13.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| 2 |
JP Morgan Chase
New York
|
-$2K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| 4 |
Morgan Stanley
New York
|
-$457 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BPI
1
Battery Partners IX
Boston,
Massachusetts
| $7.11M | – | – | – |
|
|
NMC
2
NEA Management Company
Timonium,
Maryland
| $5.69M | – | – | – |
|
|
PCM
3
PAR Capital Management
Boston,
Massachusetts
| $3.03M | – | – | – |
|
|
PA
4
Perceptive Advisors
New York
| $1.36M | – | – | – |
|
|
SM
5
Sabby Management
Miami Beach,
Florida
| $1.07M | +$13.8K | +3,733 | +1% |
|
|
KCM
6
Knoll Capital Management
Miami,
Florida
| $405K | – | – | – |
|
|
SSB
7
Sandy Spring Bank
Olney,
Maryland
| $30K | – | – | – |
|
|
8
Morgan Stanley
New York
| $10K | -$457 | -124 | -4% |
|
|
9
Bank of America
Charlotte,
North Carolina
| $8K | -$4 | -1 | -0% |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$3K | -786 | Closed |
|
|
11
JP Morgan Chase
New York
| – | -$2K | -675 | Closed |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| – | -$1K | -200 | Closed |
|
CSBR Hedge Fund Activity: Q1 2016 in Review
9 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q1 2016, worth a combined $18.7M — up 2% from $18.3M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CSBR and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, adding an estimated $13.8K. The largest seller was UBS Group, exiting entirely with an estimated $3K sold.
- 9 institutional investors held Champions Oncology (CSBR) as of Q1 2016, down from 12 in Q4 2015.
- Funds reported $18.7M of Champions Oncology stock for Q1 2016, up 2% quarter-over-quarter.
- 0 funds opened new Champions Oncology positions in Q1 2016 and 3 closed out, a net change of -3 holders.
- The largest Champions Oncology buyer in Q1 2016 was Sabby Management, an estimated $13.8K added.
- The largest Champions Oncology seller in Q1 2016 was UBS Group, an estimated $3K sold.
Based on aggregated 13F filings for Q1 2016.